Phase 1-2 MAHCT w/ TCell Depleted Graft w/ Simultaneous Infusion Conventional and Regulatory T Cell
Stanford University
Stanford University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Fate Therapeutics
Takeda
Teva Branded Pharmaceutical Products R&D, Inc.
Novartis
National Cancer Institute (NCI)
Novartis
M.D. Anderson Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Stanford University
Fred Hutchinson Cancer Center
Washington University School of Medicine
Baylor College of Medicine
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
M.D. Anderson Cancer Center
Bristol-Myers Squibb
Bristol-Myers Squibb